通策医疗股份有限公司关于审计机构变更项目质量控制复核人的公告

Core Viewpoint - The company has announced a change in the quality control reviewer for its 2025 annual audit, appointing Xu Juping in place of Wang Qichao due to internal adjustments at the auditing firm Zhonghui [1][4]. Group 1: Change in Quality Control Reviewer - The company held its 10th Board of Directors' ninth meeting on April 25, 2025, and the 2024 annual shareholders' meeting on June 5, 2025, where it approved the appointment of Zhonghui Certified Public Accountants as the auditing firm for the 2025 fiscal year [1]. - The original quality control reviewer Wang Qichao has been replaced by Xu Juping for the 2025 audit services due to internal adjustments at Zhonghui [1]. Group 2: Reviewer Background - The new quality control reviewer Xu Juping has no criminal penalties or administrative sanctions from regulatory bodies in the past three years [2]. - There are no circumstances that could affect the independence of the new quality control reviewer [3]. Group 3: Impact of Change - The transition of responsibilities during this change will be orderly, and it will not affect the financial statement audit and internal control audit for the 2025 fiscal year [4].